Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 34,376 | 19,146 | 9,883 | 9,574 | 9,893 |
| Gross Profit | 34,376 | 19,146 | 9,883 | 9,574 | 9,893 |
| Operating Expenses | 31,551 | 18,721 | 19,415 | 16,856 | 11,019 |
| Operating Income | 2,825 | 425 | -9,532 | -7,282 | -1,126 |
| Interest Expense | 0 | -139 | 0 | 0 | 15 |
| Other Income | 176 | 3 | -16,728 | -9,334 | 221 |
| Pre-tax Income | 3,001 | 567 | -26,260 | -16,616 | -920 |
| Net Income Continuous | 3,100 | 567 | -26,260 | -16,616 | -920 |
| Net Income | $3,100 | $567 | $-26,260 | $-16,616 | $-920 |
| EPS Basic Total Ops | 197.90 | 0.05 | -2.50 | -199.85 | -1.05 |
| EPS Basic Continuous Ops | 197.77 | 0.05 | -2.49 | -199.71 | -0.64 |
| EPS Diluted Total Ops | 197.90 | 0.05 | -2.50 | -199.85 | -1.05 |
| EPS Diluted Continuous Ops | 197.78 | 0.04 | -2.49 | -199.71 | -0.64 |
| EBITDA(a) | $3,727 | $752 | $-9,406 | $-7,189 | $-1,048 |